ROVI PHARMA TECHNOLOGY RDI

Promoteur – Intermédiaire Financier

LABORATORIOS FARMACEUTICOS ROVI SA

Lieu

• Espagne

Description

The project concerns the promoter's research, development and innovation (RDI) activities for various drug-delivery technologies, including preclinical development and clinical studies.

Objectifs

ROVI's pharmacological investigations involved in the project strengthen ROVI's innovativeness and help the company to maintain its competitive edge and expand its international footprint.

Secteur(s)

• Industrie - Industrie manufacturière

Montant BEI envisagé (montant approximatif)

EUR 45 million

Coût total (montant approximatif)

EUR 94 million

Aspects environnementaux

The Bank will require that projects financed under this operation comply with applicable domestic and EU legislation, as appropriate.

Passation des marchés

The Bank will require that projects financed under this operation comply with applicable domestic and EU legislation.

Statut

Signé - 21/12/2017